Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH) With Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00013598
What this trial is testing

Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

Who this might be right for
Fatty LiverNonalcoholic Steatohepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Study completedNCT04669158
What this trial is testing

Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic SteatohepatitisFibrosis
Stanford University 53
Testing effectiveness (Phase 2)Looking for participantsNCT06599918
What this trial is testing

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)

Who this might be right for
Fatty LiverObesityHepatic Fibrosis+3 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Testing effectiveness (Phase 2)Study completedNCT02960204
What this trial is testing

Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension

Who this might be right for
CirrhosisPortal HypertensionNon-alcoholic Steatohepatitis
Histogen 263
Testing effectiveness (Phase 2)Study completedNCT05011305
What this trial is testing

Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis

Who this might be right for
Nonalcoholic SteatohepatitisFibrosis
Zydus Therapeutics Inc. 189
Testing effectiveness (Phase 2)UnknownNCT05751720
What this trial is testing

Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisType 2 Diabetes+1 more
Dr Adnan Agha 30
Early research (Phase 1)Study completedNCT05835180
What this trial is testing

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Who this might be right for
Non-alcoholic SteatohepatitisHepatic ImpairmentCirrhosis
Sagimet Biosciences Inc. 48
Not applicableUnknownNCT05065593
What this trial is testing

The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Steatohepatitis
Hacettepe University 26
Not applicableActive Not RecruitingNCT06842563
What this trial is testing

Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial

Who this might be right for
Hepatocellular Carcinoma (HCC)
Singlera Genomics Inc. 900
Not applicableLooking for participantsNCT06308757
What this trial is testing

Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis

Who this might be right for
NASHNAFLDObesity+1 more
University of Bologna 42
Testing effectiveness (Phase 2)Study completedNCT02217475
What this trial is testing

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Tobira Therapeutics, Inc. 289
Large-scale testing (Phase 3)WithdrawnNCT06594523
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

Who this might be right for
MASHNASHMetabolic Dysfunction-associated Steatohepatitis+3 more
Sagimet Biosciences Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Testing effectiveness (Phase 2)Study completedNCT05809934
What this trial is testing

Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
AstraZeneca 220